Craig David Gordon
Algemeen Directeur bij Gordonmd Global Investments LP
Profiel
Dr. Craig D.
Gordon is a Founder, CEO & CIO at Gordonmd Global Investments LP.
Prior He worked at The Capital Group for 10+ years as an Equity Investment Analyst investing in and covering U.S.
and Japanese biotechnology and pharmaceutical companies.
He also worked for the Cowen Group in New York as a Biotechnology Equity Research Analyst and Associate before joining Capital Group in 2010.
He received his undergraduate degree from Cornell University, an MBA from The Fuqua School of Business and a doctorate degree from the University of Miami.
Actieve functies van Craig David Gordon
Bedrijven | Functie | Begin |
---|---|---|
Gordonmd Global Investments LP
Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Algemeen Directeur | 01-01-2021 |
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Directeur/Bestuurslid | - |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Craig David Gordon
Bedrijven | Functie | Einde |
---|---|---|
Capital Research & Management Co. (Global Investors)
Capital Research & Management Co. (Global Investors) Investment ManagersFinance Capital Research & Management Co. (Global Investors), do-business-as Capital Research Global Investors (CRGI), is an investment advisor headquartered in Los Angeles, California. The firm is a division of Capital Research & Management Co. (CR&M), the original company of the Capital Group Cos., which was founded in 1931 by Jonathan Bell Lovelace. In 2008, CR&M disaggregated their equity investment operations to become known as Capital Research Global Investors and Capital World Investors. Capital World Investors is the retail entity of the Capital Group. Institutional management services in North America are provided by Capital Guardian. Institutional management services are provided globally by Capital International. | Analyst-Equity | 01-05-2021 |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Analyst-Equity | 31-05-2010 |
Opleiding van Craig David Gordon
Cornell University | Undergraduate Degree |
University of Miami | Doctorate Degree |
The Fuqua School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Capital Research & Management Co. (Global Investors)
Capital Research & Management Co. (Global Investors) Investment ManagersFinance Capital Research & Management Co. (Global Investors), do-business-as Capital Research Global Investors (CRGI), is an investment advisor headquartered in Los Angeles, California. The firm is a division of Capital Research & Management Co. (CR&M), the original company of the Capital Group Cos., which was founded in 1931 by Jonathan Bell Lovelace. In 2008, CR&M disaggregated their equity investment operations to become known as Capital Research Global Investors and Capital World Investors. Capital World Investors is the retail entity of the Capital Group. Institutional management services in North America are provided by Capital Guardian. Institutional management services are provided globally by Capital International. | Finance |
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Health Technology |
Gennao Bio, Inc.
Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Health Technology |
Gordonmd Global Investments LP
Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Finance |